Keymed Biosciences Inc. (HKG: 2162)

Keymed Biosciences Revenue

Keymed Biosciences had revenue of 54.68M CNY in the half year ending June 30, 2024, a decrease of -45.32%. This brings the company's revenue in the last twelve months to 81.65M, down -75.04% year-over-year. In the year 2023, Keymed Biosciences had annual revenue of 354.10M with 253.87% growth.

• Revenue (ttm): 81.65M CNY
• Revenue Growth: -75.04%
• P/S Ratio: 87.93
• Revenue / Employee: 88.08K CNY
• Employees: 927
• Market Cap: 8.13B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	354.10M	254.03M	253.87%
Dec 31, 2022	100.06M	-10.21M	-9.26%
Dec 31, 2021	110.27M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-